Found 39 matching trials
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants PHASE2 The objective of the study is to evaluate the safety, tolerability, and imm...
Show More Status
Active Not Recruiting
Location
The Children's Clinic of Jonesboro, P.A
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination PHASE3 The study will evaluate the safety, tolerability, and immunogenicity of VAX...
Show More Status
Active Not Recruiting
Location
Chinle Center for Indigenous Health
Learn More & Join Trial
Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3) PHASE3 This is a phase 3, randomized, double-blind, active comparator-controlled s...
Show More Location
Central Research Associates ( Site 0067)
Learn More & Join Trial
Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant PHASE1 Streptococcus pneumoniae is a common bacteria and major cause of serious in...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults PHASE2 The objective of the study is to evaluate the safety and tolerability of a ...
Show More Location
Accel Research Sites-Birmingham Clinical Research Unit
Learn More & Join Trial
Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults PHASE3 The purpose of this study is to assess the ability of RSVPreF3 OA investiga...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age PHASE3 The purpose of this study is to assess how well-tolerated GSK's investigati...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine PHASE1 A first-in-human, Phase 1 trial to evaluate safety, tolerability, and immun...
Show More Location
Canadian Center for Vaccinology, IWK Health Centre
Learn More & Join Trial
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age PHASE1 The main purpose of this study is to evaluate safety and reactogenicity of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs PHASE4 This clinical trial aims to evaluate the effect of temporary methotrexate (...
Show More Location
Reumatology division of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
Learn More & Join Trial